glp-1 obesity drug news today september 29 2025 More people with type 1 diabetes are using drugs, study finds, despite limited evidence on safety or effectiveness GLP-1 Agonists Market Report 2025-2033,

GLP-1 medications like Ozempic and Mounjaro may support fertility by aiding weight loss, reducing inflammation, and improving hormone balance, but theyre not a cure for infertility

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both of Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.

Daily GLP-1 support supplement formulated to complement weight loss medications

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

There is growing evidence that GLP-1-receptor agonist (GLP-1-RA) use in patients who regained weight after bariatric surgery has resulted in significant weight loss